about
Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markersElevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomasTargeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.Reporting tumor molecular heterogeneity in histopathological diagnosis.Impact of MIF gene promoter polymorphism on F508del cystic fibrosis patientsDNA qualification workflow for next generation sequencing of histopathological samples.Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel.Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortiumProtein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors.Receptor-type protein tyrosine phosphatase gamma (PTPgamma), a new identifier for myeloid dendritic cells and specialized macrophages.Immunohistochemical detection of arginine methylated proteins (MeRP) in archival tissues.Expression of transmembrane protein tyrosine phosphatase gamma (PTPgamma) in normal and neoplastic human tissues.Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.Splice variants as novel targets in pancreatic ductal adenocarcinoma.Both HIV- and EIAV-based lentiviral vectors mediate gene delivery to pancreatic cancer cells and human pancreatic primary patient xenografts.ICAT is a novel Ptf1a interactor that regulates pancreatic acinar differentiation and displays altered expression in tumours.CD71 in Gestational Pathology: A Versatile Immunohistochemical Marker With New Possible Applications.High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas.High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers.Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic CarcinosarcomaMixed Adenoneuroendocrine Carcinomas of the Gastrointestinal Tract: Targeted Next-Generation Sequencing Suggests a Monoclonal Origin of the Two ComponentsERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistanceGenetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms
P50
Q28258774-99D3556F-8126-43BC-B9EC-A06F5F946F23Q31038443-FDAD8EF8-6CDC-473B-A52D-5BB439C6D71FQ33581027-3D9166B1-D5FF-4C82-AF35-BAE79BA5DD9BQ33754040-C9E62127-BC68-4990-84F5-E9D512B9057CQ33757122-23BFE543-6B0A-41DF-9843-8FC799819B8BQ34050798-72ACF43A-D836-4F23-A89D-49A3567A725DQ34689530-CF520EC9-1E25-4F91-81BC-644EABB323C0Q34769357-5F5A5FD1-0134-496E-8937-F0416451B46EQ35043965-78BC1901-6608-4EAB-8E52-C72BA6C56469Q35053271-C12A980A-29EE-46E0-AC6F-EF95100AE15AQ37280969-D70420D2-86BB-446D-B343-759570FC15DFQ38404841-8DF52CE8-81CC-4C07-9F42-B1B92DF446E2Q38413703-BDBCAF65-E67D-45DB-9D4E-70151E00988DQ38433303-A5F429E1-335D-493D-B711-5C4B249A5A34Q39642161-BE1EC823-8D73-42AA-BBA2-E807E4C05C2BQ42216004-69002EF8-0F9E-476C-B61D-1341F3B1B862Q45868824-96273F7F-75B9-4A30-9BD1-D904F77EEC77Q46563062-BFA747D4-53D5-40AC-AE0E-DCBA333A58CCQ47205279-19FD7808-50F6-4D84-A921-7709D20CBBE8Q54352691-F216070B-E650-4CEE-BA38-311ECDAA71FBQ54542254-0953B58D-726C-49AC-BBA2-E9B8F1D02F74Q55523920-A981E7B4-DD4D-41D9-AD8B-A47117B1DDB1Q57422624-007F6F7F-C6A1-43A2-BB0F-3E2E2933F82EQ57425536-98E05883-2838-4047-BACD-EC98F1A58014Q61884085-224FF618-A94E-436A-ABA0-9A8DAB537225Q64283563-F0C916D1-57AE-493C-A994-A985B69B2F0B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrea Mafficini
@ast
Andrea Mafficini
@en
Andrea Mafficini
@es
Andrea Mafficini
@nl
Andrea Mafficini
@sl
type
label
Andrea Mafficini
@ast
Andrea Mafficini
@en
Andrea Mafficini
@es
Andrea Mafficini
@nl
Andrea Mafficini
@sl
prefLabel
Andrea Mafficini
@ast
Andrea Mafficini
@en
Andrea Mafficini
@es
Andrea Mafficini
@nl
Andrea Mafficini
@sl
P106
P1153
9745667000
P31
P496
0000-0002-7471-3121